Innovative Blood Test Created For Coronary Artery Disease Patients
Researchers from the University of Melbourne and Austin Health have created an innovative blood test that can help patients with coronary artery disease to predict their risk of heart attack and death.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Treatment?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
The test can detect ACE2, an enzyme that is an essential regulator of heart function.
Results from the test were presented by the researchers at The Austin health and University of Melbourne. It stated that patients with coronary artery disease who had high ACE2 levels circulating in their blood were greatly at risk of suffering from a heart attack within a period of 10 years.
This study has the possibility to change clinical practice for coronary artery disease which continues to be the leading cause of death in Australia, says Professor Louise Burrell.
“We have come a long way in treating coronary artery disease, but certain patients continue to be at high risk of dying,”
“This new blood test helped identify such patients who may derive benefit from more aggressive treatment.”
The researchers enlisted 79 patients with coronary artery disease. During the 10-year follow up period, 46% of patients experienced heart attacks, heart failure and death.
Based from the findings published in journal PLOS ONE, these incidents happened in patients with the highest level of ACE2.
“If this were the case, the ACE2 blood test could be offered to all patients with coronary artery disease as part of their risk assessment,” Prof Burrell said.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
